Small biotech — big ambitions. Viralytics’ oncolytics therapy makes the showcase round at #AACR17 with positive combo snapshot
PHOTO: © AACR/Todd Buchanan 2017
WASHINGTON, DC — When you talk to Viralytics CEO Malcolm McColl, he has a habit of reminding his …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
